Myeong‐Cherl Kook
机构：National Cancer Center, National Cancer Center · ORCID：0000-0002-3435-3301
发表论文 231 篇 · 总被引 8814 次 · h-index 51
代表论文
- PRODIGY: A Phase III Study of Neoadjuvant Docetaxel, Oxaliplatin, and S-1 Plus Surgery and Adjuvant S-1 Versus Surgery and Adjuvant S-1 for Resectable Advanced Gastric Cancer (2021 · Journal of Clinical Oncology · 被引 372)
- Development and validation of deep learning classifiers to detect Epstein-Barr virus and microsatellite instability status in gastric cancer: a retrospective multicentre cohort study (2021 · The Lancet Digital Health · 被引 127)
- A Comprehensive and Comparative Review of Global Gastric Cancer Treatment Guidelines (2022 · Journal of the Korean Gastric Cancer Association · 被引 68)
- Neoadjuvant Docetaxel, Oxaliplatin, and S-1 Plus Surgery and Adjuvant S-1 for Resectable Advanced Gastric Cancer: Updated Overall Survival Outcomes From Phase III PRODIGY (2024 · Journal of Clinical Oncology · 被引 55)
- Smad4 and p53 synergize in suppressing autochthonous intestinal cancer (2022 · Cancer Medicine · 被引 55)
- A Standardized Pathology Report for Gastric Cancer: 2nd Edition (2023 · Journal of the Korean Gastric Cancer Association · 被引 32)